Transpact Enterprises Share Price

Transpact Enterprises Limited was incorporated as a Private Limited Company with the name Transpact Enterprises Private Limited on May 12, 2013. Further, the status of the Company was changed to a Public Limited Company and the name of the Company was changed to Transpact Enterprises Limited and a fresh Certificate of Incorporation was granted to the Company on April 16, 2019 by the Registrar of Companies, Mumbai. The Company is the first startup to get listed on the BSE Startup Platform. It is a SINE, IIT Bombay incubated MedTech startup to provide innovative, costeffective and comprehensive solutions, products with strategic partnerships and collaborative relationships to help specially abled people to transcend their barriers. We are a design, development, manufacturing, and distribution firm for therapeutic devices and rehabilitation services with analytics and management software system. Company is an ISO 13485:2016 ISO 9001:2015 certified company for Medical Devices and quality management system.. The products include Vestibulator which is a compact, mechanized, innovative therapeutic healthcare device which is ergonomically designed to provide stimulations for vestibular, neuro developmental and sensory integration therapy. Another product is Rehabsoft which is a cloudbased therapy and rehabilitation software solution developed specifically to streamline and manage the therapy, rehab clinical documentation, nutrition schedule, administrative processes, and training and individual education plan. Apart from these, one more product includes Vestibulator Chair which is an ergonomicallydesigned compact vestibular therapy device for at home therapy of children suffering from vestibular dysfunction and developmental disorders. The chair is designed to make the inhouse therapy program more purposeful by adding more therapeutic benefit by making athome therapy repetitive, accurate and specific. Also, enabling the caretakers to give the prescribed therapy dose with a lot of ease. The Companys software solution RehabSoft, Electronic Medical Records (EMR) processing, device administration, communications and streamlines patient billing. The solution is based on Internet of Things (lOT) technologies that turns Vestibulator therapy data into electronic medical record and sends them to the private cloud, where data analytics can be performed to better evaluate patients condition. The RehabSoft improves medical care, support EMRs, enables patient data sharing among therapy centres and increases staff efficiency. The Companys integrated product offering limits the need of existing old techniques for vestibular, neurodevelopmental and sensory integration therapy. The Company constantly keeps abreast with the latest technology as per the requirement of the industry. The Company came up with a Public Issue of 1,04,000 Equity Shares by raising money from public aggregating to Rs 1.35 Crore in August, 2019.

As of 22 Jan 2026, Transpact Enterprises share price is ₹130.4. The stock opened at ₹130.4 and had closed at ₹137.2 the previous day. During today’s trading session, Transpact Enterprises share price moved between ₹130.40 and ₹130.40, with an average price for the day of ₹130.40. Over the last 52 weeks, the stock has recorded a low of ₹119.55 and a high of ₹299.40. In terms of performance, Transpact Enterprises share price has declined by 50.1% over the past six months and has declined by 25.73% over the last year.